Czechia – Antineoplastic and immunomodulating agents – Léčivý přípravek s obsahem účinné látky pembrolizumab
Fakultní nemocnice Plzeň awarded Kč294M to Merck Sharp & Dohme s.r.o. for Professional Services & Consulting in April 2024 — one of 777 awards this buyer has made, above its typical award size.
Buying agency
Fakultní nemocnice PlzeňWinning supplier
Merck Sharp & Dohme s.r.o.Contract description
Czechia – Antineoplastic and immunomodulating agents – Léčivý přípravek s obsahem účinné látky pembrolizumab
Related awards · Fakultní nemocnice Plzeň
777 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-343521-2025VERTEX PHARMACEUTICALS (IRELAND) LIMITEDKč294M28 May 2025 Healthcare
- ocds-ted-586392-2025Avenier a.s.Kč286M09 Sep 2025 Professional Services
- ocds-ted-6198-2026Bristol-Myers Squibb spol. s r.o.Kč267M07 Jan 2026 Professional Services
Other wins · Merck Sharp & Dohme s.r.o.
49 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-324979-2025Fakultní Thomayerova nemocniceKč647M20 May 2025 Professional Services
- ocds-ted-531271-2025Fakultní nemocnice Hradec KrálovéKč577M13 Aug 2025 Professional Services
- ocds-ted-120271-2025Všeobecná fakultní nemocnice v PrazeKč362M24 Feb 2025 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Fakultní nemocnice Plzeň and Merck Sharp & Dohme s.r.o. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back